British Pakistani and British Indian patients are prone to self regulating their tablet intake to control type 2 diabetes. Lawton and colleagues (p 1247) used in-depth interviews with 32 patients to explore their perceptions and experiences of taking oral hypoglycaemic drugs. Most of the interviewees trusted their doctors' expertise and considered the medicines available in Britain to be better than those available in the Indian subcontinent. They perceived drugs in general to be harmful, however, if taken for long periods of time, with other medicines, or without traditional foods.
Figure 1.
Credit: CHRIS PRIEST AND MARK CLARKE/SPL